Lomitapide


( Last Updated : July 8, 2014)
Generic Name:
Lomitapide
Project Status:
Complete
Therapeutic Area:
Hypercholesterolemia, homozygous familial
Manufacturer:
Aegerion Pharmaceuticals (Canada) Ltd.
Call for patient/clinician input open:
Brand Name:
Juxtapid
Project Line:
Reimbursement Review
Project Number:
SR0386-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Hypercholesterolemia, Homozygous Familial
Recommendation Type:
Do not list
Final Recommendation: